Delivery Order SPE2DB22D3301-SPE2DB25FY3RF

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $10,651.72 and is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price and a ceiling value of $8,761.71. It was awarded on April 16, 2025, with an ultimate completion date of April 17, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $12,154.60. It is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $14,356.96 and a period of performance through April 16, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used for the treatment of overactive bladder. The total ceiling value of the contract is $5,307.02, and it will run through December 10, 2024. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a pharmaceutical product used for the treatment of overactive bladder. The contract has a ceiling value of $4,816.17 and runs until February 10, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Myrbetriq ER 50 mg tablets, a medication used for the treatment of overactive bladder. The contract has a firm fixed-price, $34,152.51 ceiling value, and an ultimate completion date of February 21, 2024. This contract award is not associated with a...
This is a $16,657.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a medication used to treat overactive bladder. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 MG Tablet 90s, a medication for overactive bladder. The contract has a ceiling value of $4,554.41 and runs through March 27, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen also holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,810.69 and an ultimate completion date of April 8, 2025. The contract is for the supply of Myrbetriq ER 50 MG tablets, a medication used for the treatment of overactive bladder. The contract is not set aside for any specific business type. AmerisourceBergen holds a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY3RF
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $12,557.35 and a performance period ending on April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside for any specific business category.

Generated 7/22/25, 9:44 AM